1) ENOblock (AP-III-a4) is developed an anti-diabetes and anti-cancer drug (termed ENOblock). We have demonstrated its effectiveness in models of type 2 diabetes and diet-induced obesity.

2) BIO (6-bromoindirubin-3′-oxime) is a compound isolated from shellfish. We are developing BIO as a drug to treat myocardial infarction.

3) Drug cocktail to enhance tissue regeneration: we have developed a drug cocktail combination that can increase cell plasticity in muscle cells and allow them to re-differentiate into other cell types. This technology is based on limb regeneration in amphibians, such as the salamander, and is being further developed to improve the healing response in damaged tissues.